A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors-Reference-Cited by-同舟云学术

A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors

Published:2017-04 Issue:2 Volume:15 Page:306-312.e3
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Necchi Andrea,Pond Gregory R.,Nicolai Nicola,Giannatempo Patrizia,Raggi Daniele,Adra Nabil,Hanna Nasser H.,Salvioni Roberto,Einhorn Lawrence H.,Albany Costantine

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference19 articles.

1. International Germ Cell Cancer Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers;J Clin Oncol,1997

2. Guidelines on testicular cancer: 2015 update;Albers;Eur Urol,2015

3. Testicular seminoma and non-seminoma: ESMO clinical practice guidelines for diagnosis, treatment, and follow up;Oldenburg;Ann Oncol,2013

4. National Comprehensive Cancer Network. NCCN guidelines: Testicular cancer. Available at: http://www.nccn.org/professionals/physician_gls/pdf/testicular.pdf Accessed: March 31, 2016.

5. Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: an update based on meta-analysis;van Dijk;Eur J Cancer,2006

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A population-based validation of the IGCCCG Update Consortium for survival in metastatic non-seminoma testis cancer;Japanese Journal of Clinical Oncology;2024-02-17

2. Extracranial Germ Cell Tumors in Children: Ten Years of Experience in Three Children’s Medical Centers in Shanghai;Cancers;2023-11-14

3. Survival of nonseminomatous germ cell tumors in pediatric patients and young adults – A stage group stratified analysis;Urologic Oncology: Seminars and Original Investigations;2022-04

4. Testicular Germ-Cell Tumors with Spermatic Cord Involvement: A Retrospective International Multi-Institutional Experience;Modern Pathology;2021-09-09

5. A 25-year review of advances in testicular cancer: Perspectives on evaluation, treatment, and future directions/challenges;Urologic Oncology: Seminars and Original Investigations;2021-09